TY - JOUR
T1 - Synthesis, characterization, antioxidant and antiparasitic activities new naphthyl-thiazole derivatives
AU - Santos, Natali de França Nibbering
AU - Junior, Natanael da Silva Bezerra
AU - de Oliveira, Jamerson Ferreira
AU - Duarte, Denise Maria Figueiredo Araújo
AU - Dos Santos Soares, José Cleberson
AU - Clara Marques, Diego Santa
AU - da Silva Santos, Aline Caroline
AU - Nogueira, Fátima
AU - Alves Pereira, Valéria Rêgo
AU - Alves de Lima, Maria Carmo
AU - da Cruz Filho, Iranildo José
N1 - Copyright © 2023. Published by Elsevier Inc.
PY - 2023/5
Y1 - 2023/5
N2 - In this work, 13 thiosemicarbazones (1a - m) and 16 thiazoles (2a - p) were obtained, which were properly characterized by spectroscopic and spectrometric techniques. The pharmacokinetic properties obtained in silico revealed that the derivatives are in accordance with the parameters established by lipinski and veber, showing that such compounds have good bioavailability or permeability when administered orally. In assays of antioxidant activity, thiosemicarbazones showed moderate to high antioxidant potential when compared to thiazoles. In addition, they were able to interact with albumin and DNA. Screening assays to assess the toxicity of compounds to mammalian cells revealed that thiosemicarbazones were less toxic when compared to thiazoles. In relation to in vitro antiparasitic activity, thiosemicarbazones and thiazoles showed cytotoxic potential against the parasites Leishmania amazonensis and Trypanosoma cruzi. Among the compounds, 1b, 1j and 2l stood out, showing inhibition potential for the amastigote forms of the two parasites. As for the in vitro antimalarial activity, thiosemicarbazones did not inhibit Plasmodium falciparum growth. In contrast, thiazoles promoted growth inhibition. This study shows in a preliminary way that the synthesized compounds have antiparasitic potential in vitro.
AB - In this work, 13 thiosemicarbazones (1a - m) and 16 thiazoles (2a - p) were obtained, which were properly characterized by spectroscopic and spectrometric techniques. The pharmacokinetic properties obtained in silico revealed that the derivatives are in accordance with the parameters established by lipinski and veber, showing that such compounds have good bioavailability or permeability when administered orally. In assays of antioxidant activity, thiosemicarbazones showed moderate to high antioxidant potential when compared to thiazoles. In addition, they were able to interact with albumin and DNA. Screening assays to assess the toxicity of compounds to mammalian cells revealed that thiosemicarbazones were less toxic when compared to thiazoles. In relation to in vitro antiparasitic activity, thiosemicarbazones and thiazoles showed cytotoxic potential against the parasites Leishmania amazonensis and Trypanosoma cruzi. Among the compounds, 1b, 1j and 2l stood out, showing inhibition potential for the amastigote forms of the two parasites. As for the in vitro antimalarial activity, thiosemicarbazones did not inhibit Plasmodium falciparum growth. In contrast, thiazoles promoted growth inhibition. This study shows in a preliminary way that the synthesized compounds have antiparasitic potential in vitro.
KW - citotoxity in animal cells
KW - Leishmania
KW - Plasmodium falciparum
KW - Thiazoles/pharmacology
KW - Thiosemicarbazones/pharmacology
KW - Trypanosoma cruzi
U2 - 10.1016/j.exppara.2023.108498
DO - 10.1016/j.exppara.2023.108498
M3 - Article
C2 - 36907541
SN - 0014-4894
VL - 248
SP - 108498
JO - Experimental Parasitology
JF - Experimental Parasitology
M1 - 108498
ER -